期刊文献+

基因工程技术构建预防性HPV疫苗 被引量:3

Construction of Prophylactic HPV Vaccines Using Genetic Engineering Technology
在线阅读 下载PDF
导出
摘要 宫颈癌的发生与高危型人乳头瘤病毒(human papillomavirus,HPV)感染高度相关已得到公认。利用基因重组技术开发HPV疫苗是目前预防宫颈癌唯一有效的方法。综述了近年来在基因工程HPV疫苗研制中广泛应用的载体表达系统及其特点,依据密码子偏爱原则优化病毒外壳蛋白基因序列显著提高外壳蛋白产量等方面的研究成果,以为进一步研制与优化HPV疫苗提供参考。 It' s commonly accepted that the infection of HPV with high-risk is the important factor in the occurrence of cervix cancer. Recombinate technologies are used to develop HPV vaccines, which is the only effective method to prevent cervix cancer so far. From the both aspects of expression vectors and codon optimization, this article reviewed the widely used expression vectors in recent years and their characteristics;As well as the research results on obviously enhancement of capsid protein by optimizing the virus capsid gene according to codon preference, which provide basis for the further manufacturing and optimization of HPV vaccines.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2008年第9期130-134,共5页 China Biotechnology
关键词 HPV 疫苗 表达系统 密码子优化 HPV Vaccines Vector expression system Codon modification
作者简介 通讯作者,电子信箱:xiahz612@sina.com
  • 相关文献

参考文献29

  • 1Franco E L, Harper D M. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine, 2005,23( 17 - 18) :2388 -2394
  • 2Villers E M, Fauquet C, Broker T R, et al. Classification of papillomaviruses. Virology, 2004,324( 1 ) :17 -27
  • 3Embers M E, Budgeon L R, Pickel M, et al. Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of I2, the minor capsid protein. Virol, 2002,76:9798 - 9805
  • 4Widdce L E, Kahn J A, Using the new HPV vaccines in clinical practice. Cleve Clin J Med, 2006,3 (10) :929 - 935
  • 5Eileen M B. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 2003,16( 1 ) : 1 - 17
  • 6Kimbauer R, Taub J, Greensyone H, et al. Efficient self- assembly of human papillomavirus type 16L1 and LI-L2 into virus-like particles. Virol, 1993,67(12) :6929 -6936
  • 7Zhang W, Carmichael J, Ferguson J. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro. Virology, 1998,243(2) :423 -431
  • 8Zhou J, Sun X Y, Stenzel D J, et al. Expression of vaccinia recombinant HPV 16 L1 and L20RF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology, 1991,185( 1 ) :251 -257
  • 9Steinbrook R. The potential of human papillomavirus vaccines. New Eng J Med, 2006,354:1109 - 111
  • 10Volpers C, Schirmacher P, Streeck R E, et al. Assembly of the major and the minor capsid protein of human papiltomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology, 1994,200(2) :504 -512

二级参考文献6

  • 1JinZHENG JunMA Xiao-FengYANG Hong-WeiCHENG Lu-ShengSIt Yi-LiWANG.Highly Efficient and Economical Baculovirus Expression System for Preparing Human Papillomavirus Type16 Virus-like Particle[J].Acta Biochimica et Biophysica Sinica,2004,36(8):548-552. 被引量:7
  • 2Angelichio PL,Beck JA,Johansen H,et al.Comparison of Several Promoters and Polyadenylation Signals for Use in Heterologous Gene Expression in Culyured Drosophila Cells.Nucleic Acids Res,1991,19:5037.
  • 3BunchT A,Grinblat Y,Goldstein LS.Characterization and Use of the Meallothionein Promoter in Cultured Drosophila melanogaster cells.Nucleic Acids,1988,16:1043,
  • 4Lilie H,Schwarz E,Rudolph R.Advances in refolding of proteins produced in E.coli.Cur Opin Biot,1998,9:442.
  • 5Gribskov M,Burgess RR.Overexpression and purification of the sigma subunit of E.coil RNA polymerase.Gene,1983,26:109.
  • 6Chen Y,Ghim SJ,Jenson AB,et al.Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.J Gen Virol,1998,79(Pt9):2137.

共引文献5

同被引文献16

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics [J]. CA Cancer J Clin,2005,55(2) :74 - 108.
  • 2Jacob B. The HPV vaccines-which to prefer [J]. Obstetrical And Gynecological Survey ,2009,64(5 ) :345 - 350.
  • 3Future Ⅱ Study Group. Quadrivalent vaccine against human papil- lomavirus to prevent high-grade cervical lesions[J]. N Engl J Med ,2007,356 : 1915 - 1927.
  • 4Kahn JA, Ding L, Huang B, et al. Mothers' intention for their daughters and themselves to receive the human papillomavirus vac- cine : a national study of nurses[J]. Pediatrics,2009,123 ( 6 ) : 1439 - 1445.
  • 5Parkin DMtBray F,Ferlay J,et al.Global cancer statistics[J].CA-Cancer J Clin,2005,55(2):74-108,.
  • 6Psyrri A,Dimaio D.Human papillomavirus in cervical andhead-and-neck cancer[J].Nat Clin Pract Oncol,2008,5(1):24.
  • 7Mao C.Prevention by hum a npapillom avirus vaccination[J].Cancer Res,2006,66(21):10229.
  • 8姜志欣,吴玉璘.HPV感染及预防性HPV疫苗研究[J].中国计划生育学杂志,2008,16(5):315-317. 被引量:5
  • 9吴雪伶,聂建辉,张春涛,吴瑜,赵晨燕,王佑春.人乳头瘤病毒(HPV)58型DNA疫苗免疫原性的初步分析[J].病毒学报,2008,24(3):196-201. 被引量:3
  • 10鲁静,玛依努尔.尼亚孜.人乳头瘤病毒(HPV)基因型与宫颈病变关系的研究进展[J].新疆医学,2008,38(6):107-110. 被引量:14

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部